Sifting through countless of stocks in the Health Care Providers & Services industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Hims & Hers Health, Inc. or Perrigo Company plc because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Hims & Hers Health, Inc. and Perrigo Company plc compare based on key financial metrics to determine which better meets your investment needs.

About Hims & Hers Health, Inc. and Perrigo Company plc

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company’s curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. The company also provides Labs which measures key markers over time and provides doctor-developed action plans. Hims & Hers Health, Inc. is based in San Francisco, California.

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Latest Health Care Providers & Services and Hims & Hers Health, Inc., Perrigo Company plc Stock News

As of December 12, 2025, Hims & Hers Health, Inc. had a $8.5 billion market capitalization, compared to the Health Care Providers & Services median of $1.2 million. Hims & Hers Health, Inc.’s stock is up 53.9% in 2025, down 5.1% in the previous five trading days and up 20.54% in the past year.

Currently, Hims & Hers Health, Inc.’s price-earnings ratio is 69.3. Hims & Hers Health, Inc.’s trailing 12-month revenue is $2.2 billion with a 6.1% net profit margin. Year-over-year quarterly sales growth most recently was 49.2%. Analysts expect adjusted earnings to reach $0.968 per share for the current fiscal year. Hims & Hers Health, Inc. does not currently pay a dividend.

As of December 12, 2025, Perrigo Company plc had a $1.8 billion market cap, putting it in the 54th percentile of all stocks. Perrigo Company plc’s stock is down 48.9% in 2025, down 2.2% in the previous five trading days and down 52.37% in the past year.

Currently, Perrigo Company plc does not have a price-earnings ratio. Perrigo Company plc’s trailing 12-month revenue is $4.3 billion with a -1.2% net profit margin. Year-over-year quarterly sales growth most recently was -4.1%. Analysts expect adjusted earnings to reach $2.772 per share for the current fiscal year. Perrigo Company plc currently has a 8.8% dividend yield.

How We Compare Hims & Hers Health, Inc. and Perrigo Company plc Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Hims & Hers Health, Inc. and Perrigo Company plc’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Hims & Hers Health, Inc. and Perrigo Company plc Growth Grades

Company	Ticker	Growth
Hims & Hers Health, Inc.	HIMS	D
Perrigo Company plc	PRGO	B

The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.

In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.

The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.

Hims & Hers Health, Inc. has a Growth Score of 32, which is Weak. Perrigo Company plc has a Growth Score of 75, which is Strong.

The Growth Grade Winner: Perrigo Company plc

As you can clearly see from the Growth Grade breakdown above, Perrigo Company plc has a more attractive growth grade than Hims & Hers Health, Inc.. For investors who focus solely on how a company is growing relative to other companies in the same industry, Perrigo Company plc could be a good stock to add to their portfolio. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Hims & Hers Health, Inc. and Perrigo Company plc’s Quality Grades

Company	Ticker	Quality
Hims & Hers Health, Inc.	HIMS	C
Perrigo Company plc	PRGO	C

Like the Value Grade, AAII’s A+ Investor Quality Grade comes from the percentile rank of key metrics. Specifically, the Quality Score is the percentile rank of the average of the percentile ranks of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and the F-Score.

The score is variable, meaning it can consider all eight measures or, should any of the eight measures not be valid, the remaining measures that are valid. To be assigned a Quality Score, stocks must have a valid (non-null) measure and corresponding ranking for at least four of the eight quality measures.

The Quality Score is used to assess the underlying “quality” of a particular stock. A higher-quality stock possesses traits associated with upside potential and reduced downside risk. Backtesting of the Quality Grade shows that stocks with higher grades, on average, outperformed stocks with lower grades over the period of 1998 through 2019.

Stocks receive better grades (higher scores) for having higher scores for the quality subcomponents and worse grades (lower scores) for lower scores for the subcomponents.

Hims & Hers Health, Inc. has a Quality Score of 54, which is Average. Perrigo Company plc has a Quality Score of 59, which is Average.

The Quality Stock Winner: No Clear Winner

Neither Hims & Hers Health, Inc. or Perrigo Company plc has a high enough Quality Grade to be considered a “winner.” Investors who are considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Hims & Hers Health, Inc. or Perrigo Company plc is the better investment when it comes to quality.

Hims & Hers Health, Inc. and Perrigo Company plc’s Momentum Grades

Company	Ticker	Momentum
Hims & Hers Health, Inc.	HIMS	C
Perrigo Company plc	PRGO	F

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Hims & Hers Health, Inc. has a Momentum Score of 59, which is Average. Perrigo Company plc has a Momentum Score of 9, which is Very Weak.

The Momentum Stock Winner: No Clear Winner

Neither Hims & Hers Health, Inc. or Perrigo Company plc has a strong enough Momentum Grade to be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Hims & Hers Health, Inc. or Perrigo Company plc is the better investment when it comes to momentum.

Other Hims & Hers Health, Inc. and Perrigo Company plc Grades

In addition to Growth, Momentum and Quality, A+ Investor also provides grades for Value and Estimate Revisions.

Earnings estimate revisions scores take into account the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, surprises beget further surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Hims & Hers Health, Inc. and Perrigo Company plc pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Hims & Hers Health, Inc. or Perrigo Company plc Stock?

Overall, Hims & Hers Health, Inc. stock has a Growth Score of 32, Momentum Score of 59 and Quality Score of 54.

Perrigo Company plc stock has a Growth Score of 75, Momentum Score of 9 and Quality Score of 59.

Comparing Hims & Hers Health, Inc. and Perrigo Company plc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.